Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder | Zendy

Raymond W. Lam | Zendy; Anthony Levitt | Zendy; Robert D. Levitan | Zendy; Erin E. Michalak | Zendy; Amy Cheung | Zendy; Rachel Morehouse | Zendy; Rajamannar Ramasubbu | Zendy; Lakshmi N. Yatham | Zendy; Edwin M. Tam | Zendy

Open Access

Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder

Author(s) -

Raymond W. Lam,

Anthony Levitt,

Robert D. Levitan,

Erin E. Michalak,

Amy Cheung,

Rachel Morehouse,

Rajamannar Ramasubbu,

Lakshmi N. Yatham,

Edwin M. Tam

Publication year - 2015

Publication title -

jama psychiatry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.531

H-Index - 365

eISSN - 2168-6238

pISSN - 2168-622X

DOI - 10.1001/jamapsychiatry.2015.2235

Subject(s) - fluoxetine , placebo , light therapy , major depressive disorder , randomized controlled trial , medicine , antidepressant , psychiatry , psychology , mood , circadian rhythm , receptor , serotonin , alternative medicine , pathology , hippocampus

Bright light therapy is an evidence-based treatment for seasonal depression, but there is limited evidence for its efficacy in nonseasonal major depressive disorder (MDD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research